These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 36522333)

  • 21. Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 Pathogenesis.
    Li J; Guo M; Tian X; Wang X; Yang X; Wu P; Liu C; Xiao Z; Qu Y; Yin Y; Wang C; Zhang Y; Zhu Z; Liu Z; Peng C; Zhu T; Liang Q
    Med; 2021 Jan; 2(1):99-112.e7. PubMed ID: 32838362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating monocytes expressing senescence-associated features are enriched in COVID-19 patients with severe disease.
    Lin Y; Postma DF; Steeneken LS; Melo Dos Santos LS; Kirkland JL; Espindola-Netto JM; Tchkonia T; Borghesan M; Bouma HR; Demaria M
    Aging Cell; 2023 Dec; 22(12):e14011. PubMed ID: 37969056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma proteomics identify potential severity biomarkers from COVID-19 associated network.
    Sahin AT; Yurtseven A; Dadmand S; Ozcan G; Akarlar BA; Kucuk NEO; Senturk A; Ergonul O; Can F; Tuncbag N; Ozlu N
    Proteomics Clin Appl; 2023 Mar; 17(2):e2200070. PubMed ID: 36217943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term predictor for COVID-19 severity from a longitudinal multi-omics study for practical application in intensive care units.
    Kugler S; Hahnefeld L; Kloka JA; Ginzel S; Nürenberg-Goloub E; Zinn S; Vehreschild MJ; Zacharowski K; Lindau S; Ullrich E; Burmeister J; Kohlhammer J; Schwäble J; Gurke R; Dorochow E; Bennett A; Dauth S; Campe J; Knape T; Laux V; Kannt A; Köhm M; Geisslinger G; Resch E; Behrens F
    Talanta; 2024 Feb; 268(Pt 1):125295. PubMed ID: 37866305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity.
    Suresh V; Mohanty V; Avula K; Ghosh A; Singh B; Reddy RK; Parida D; Suryawanshi AR; Raghav SK; Chattopadhyay S; Prasad P; Swain RK; Dash R; Parida A; Syed GH; Senapati S
    FASEB J; 2021 Jul; 35(7):e21713. PubMed ID: 34105201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 Omicron breakthrough infection.
    Wang H; Liu C; Xie X; Niu M; Wang Y; Cheng X; Zhang B; Zhang D; Liu M; Sun R; Ma Y; Ma S; Wang H; Zhu G; Lu Y; Huang B; Su P; Chen X; Zhao J; Wang H; Shen L; Fu L; Huang Q; Yang Y; Wang H; Wu C; Ge W; Chen C; Huo Q; Wang Q; Wang Y; Geng L; Xie Y; Xie Y; Liu L; Qi J; Chen H; Wu J; Jiang E; Jiang W; Wang X; Shen Z; Guo T; Zhou J; Zhu P; Cheng T
    Immunity; 2023 Jun; 56(6):1410-1428.e8. PubMed ID: 37257450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 infection induces a long-lived pro-inflammatory transcriptional profile.
    Zhang JY; Whalley JP; Knight JC; Wicker LS; Todd JA; Ferreira RC
    Genome Med; 2023 Sep; 15(1):69. PubMed ID: 37700317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients.
    Engel JJ; van der Made CI; Keur N; Setiabudiawan T; Röring RJ; Damoraki G; Dijkstra H; Lemmers H; Ioannou S; Poulakou G; van der Meer JWM; Giamarellos-Bourboulis EJ; Kumar V; van de Veerdonk FL; Netea MG; Ziogas A
    Front Immunol; 2023; 14():1233318. PubMed ID: 37614228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-Cell RNA Sequencing Reveals HIF1A as a Severity-Sensitive Immunological Scar in Circulating Monocytes of Convalescent Comorbidity-Free COVID-19 Patients.
    May L; Chu CF; Zielinski CE
    Cells; 2024 Feb; 13(4):. PubMed ID: 38391913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVIDomics: The Proteomic and Metabolomic Signatures of COVID-19.
    Costanzo M; Caterino M; Fedele R; Cevenini A; Pontillo M; Barra L; Ruoppolo M
    Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
    Loo L; Waller MA; Moreno CL; Cole AJ; Stella AO; Pop OT; Jochum AK; Ali OH; Denes CE; Hamoudi Z; Chung F; Aggarwal A; Low JKK; Patel K; Siddiquee R; Kang T; Mathivanan S; Mackay JP; Jochum W; Flatz L; Hesselson D; Turville S; Neely GG
    PLoS Biol; 2023 Feb; 21(2):e3001967. PubMed ID: 36757924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of Serological Biomarkers of SARS-CoV-2 Infection in Convalescent Samples From Severe, Moderate and Mild COVID-19 Cases.
    Castillo-Olivares J; Wells DA; Ferrari M; Chan ACY; Smith P; Nadesalingam A; Paloniemi M; Carnell GW; Ohlendorf L; Cantoni D; Mayora-Neto M; Palmer P; Tonks P; Temperton NJ; Peterhoff D; Neckermann P; Wagner R; Doffinger R; Kempster S; Otter AD; Semper A; Brooks T; Albecka A; James LC; Page M; Schwaeble W; Baxendale H; Heeney JL
    Front Immunol; 2021; 12():748291. PubMed ID: 34867975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers and Immune Repertoire Metrics Identified by Peripheral Blood Transcriptomic Sequencing Reveal the Pathogenesis of COVID-19.
    Liu Y; Wu Y; Liu B; Zhang Y; San D; Chen Y; Zhou Y; Yu L; Zeng H; Zhou Y; Zhou F; Yang H; Yin L; Huang Y
    Front Immunol; 2021; 12():677025. PubMed ID: 34504487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune response pattern across the asymptomatic, symptomatic and convalescent periods of COVID-19.
    Chen Y; Zhang N; Zhang J; Guo J; Dong S; Sun H; Gao S; Zhou T; Li M; Liu X; Guo Y; Ye B; Zhao Y; Yu T; Zhan J; Jiang Y; Wong CCL; Gao GF; Liu WJ
    Biochim Biophys Acta Proteins Proteom; 2022 Feb; 1870(2):140736. PubMed ID: 34774760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune transcriptome analysis of COVID-19 patients infected with SARS-CoV-2 variants carrying the E484K escape mutation identifies a distinct gene module.
    Lee HK; Knabl L; Knabl L; Wieser M; Mur A; Zabernigg A; Schumacher J; Kapferer S; Kaiser N; Furth PA; Hennighausen L
    Sci Rep; 2022 Feb; 12(1):2784. PubMed ID: 35181735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.
    Bernardes JP; Mishra N; Tran F; Bahmer T; Best L; Blase JI; Bordoni D; Franzenburg J; Geisen U; Josephs-Spaulding J; Köhler P; Künstner A; Rosati E; Aschenbrenner AC; Bacher P; Baran N; Boysen T; Brandt B; Bruse N; Dörr J; Dräger A; Elke G; Ellinghaus D; Fischer J; Forster M; Franke A; Franzenburg S; Frey N; Friedrichs A; Fuß J; Glück A; Hamm J; Hinrichsen F; Hoeppner MP; Imm S; Junker R; Kaiser S; Kan YH; Knoll R; Lange C; Laue G; Lier C; Lindner M; Marinos G; Markewitz R; Nattermann J; Noth R; Pickkers P; Rabe KF; Renz A; Röcken C; Rupp J; Schaffarzyk A; Scheffold A; Schulte-Schrepping J; Schunk D; Skowasch D; Ulas T; Wandinger KP; Wittig M; Zimmermann J; Busch H; Hoyer BF; Kaleta C; Heyckendorf J; Kox M; Rybniker J; Schreiber S; Schultze JL; Rosenstiel P; ;
    Immunity; 2020 Dec; 53(6):1296-1314.e9. PubMed ID: 33296687
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical COVID-19 is associated with distinct leukocyte phenotypes and transcriptome patterns.
    Christensen EE; Jørgensen MJ; Nore KG; Dahl TB; Yang K; Ranheim T; Huse C; Lind A; Nur S; Stiksrud B; Jenum S; Tonby K; Holter JC; Holten AR; Halvorsen B; Dyrhol-Riise AM
    J Intern Med; 2021 Sep; 290(3):677-692. PubMed ID: 34080738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2-specific serological and functional T cell immune responses during acute and early COVID-19 convalescence in solid organ transplant patients.
    Favà A; Donadeu L; Sabé N; Pernin V; González-Costello J; Lladó L; Meneghini M; Charmetant X; García-Romero E; Cachero A; Torija A; Rodriguez-Urquia R; Crespo E; Teubel I; Melilli E; Montero N; Manonelles A; Preyer R; Strecker K; Ovize A; Lozano JJ; Sidorova J; Cruzado JM; Le Quintrec M; Thaunat O; Bestard O
    Am J Transplant; 2021 Aug; 21(8):2749-2761. PubMed ID: 33756051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks.
    Ruhl L; Pink I; Kühne JF; Beushausen K; Keil J; Christoph S; Sauer A; Boblitz L; Schmidt J; David S; Jäck HM; Roth E; Cornberg M; Schulz TF; Welte T; Höper MM; Falk CS
    Signal Transduct Target Ther; 2021 Dec; 6(1):418. PubMed ID: 34893580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.